AngII‐treated mice displayed an increased heart/body weight ratio, with a 17% increase in non‐aneurysmal and a 36% increase in aneurysmal AngII‐treated mice compared to PBS‐treated control animals (Table S1), demonstrating more pronounced cardiac hypertrophy in aneurysmal AngII‐treated mice. Here, AGT is linked to cardiac hypertrophy.